Starting on April 1st, 2024, adults 18 years old and older can cultivate up to three cannabis plants in their private residences. As part of Germany’s adult-use cannabis legalization model, cannabis clones and seeds are legal for purchase across the country. According to the results of a recent YouGov poll, many German adults have already made such purchases.
When asked, ‘Have you purchased cannabis seeds for personal cultivation since cannabis legalization?,’ 7% of YouGov poll participants answered that they have already purchased cannabis clones and/or seeds.
Additionally, 11% of poll participants stated that while they have not made a purchase yet, but that they plan on doing so in the future. Four percent of poll participants stated that they didn’t know or didn’t provide an answer, and the remainder indicated that they have no current plans to purchase cannabis clones or seeds.
When the results are filtered by age, 14% of poll participants aged 18-34 indicated that they had already purchased cannabis clones and/or seeds. Only 2% of German adults over 55 who participated in the YouGov poll indicated that they had already purchased cannabis clones and/or seeds. The poll was conducted on May 13th, 2024 and involved 3,375 surveyed German adults.
A previous German market analysis by Cannabis Industry Data estimated that there are roughly 6 million adult cannabis consumers in Germany. Germany is the largest country to ever pass a national adult-use legalization measure. Noncommercial cannabis clubs are set to launch in July in Germany, and regional adult-use cannabis commerce pilot trials are expected to launch by the end of the year.
Germany’s domestic medical cannabis production quota system, which has historically limited the amount of medical cannabis produced in Germany, is no longer in place. Germany imported 34.6 tons of medical cannabis products in 2023 alone. The recent changes will contribute to tremendous growth for Germany’s domestic medical cannabis industry in the coming years.
According to a recent market analysis by Research and Markets, the overall emerging legal European medical cannabis industry is set to undergo considerable growth between now and 2028.
“The burgeoning Europe medical marijuana market is poised for robust growth, as evidenced by the latest market insights which project an impressive leap from US$ 3,414.26 million in 2022 to US$ 9,703.38 million by 2028.” the researchers stated in a press release.
“This significant expansion is characterized by a Compound Annual Growth Rate (CAGR) of 19.0% over the forecast period.” they also stated.
The global legal medical cannabis market is projected to reach $82.5 billion by 2030 according to a separate report by Research and Markets. The legal medical cannabis market was worth an estimated $32.3 billion in 2023 according to the report.